Filing Details

Accession Number:
0001209191-20-059384
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-19 16:23:54
Reporting Period:
2020-11-17
Accepted Time:
2020-11-19 16:23:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1770787 10X Genomics Inc. TXG () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189140 R John Stuelpnagel C/O 10X Genomics, Inc.
6230 Stoneridge Mall Road
Pleasanton CA 94588
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2020-11-17 400 $133.18 510,591 No 4 S Direct
Class A Common Stock Disposition 2020-11-17 1,576 $135.41 509,015 No 4 S Direct
Class A Common Stock Disposition 2020-11-17 4,424 $136.19 504,591 No 4 S Direct
Class A Common Stock Disposition 2020-11-17 1,100 $136.97 503,491 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
  2. This transaction was executed in multiple trades at prices ranging from $132.71 to $133.66. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  3. This transaction was executed in multiple trades at prices ranging from $134.73 to $135.71. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  4. This transaction was executed in multiple trades at prices ranging from $135.74 to $136.69. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  5. This transaction was executed in multiple trades at prices ranging from $136.77 to $137.20. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.